A comprehensive electrooculography measurement system and protocols for screening myasthenia gravis

Area of Science:

• Neurology
• Biomedical Engineering
• Ophthalmology

Background:

• Myasthenia Gravis (MG) is a severe neuromuscular disorder with potentially fatal respiratory complications.
• Current diagnostic methods like SFEMG and RNS have significant limitations, including invasiveness, cost, and reduced sensitivity in mild cases.
• Previous research suggests eye movement abnormalities in MG can be quantified using electrooculography (EOG).

Purpose of the Study:

• To develop and present a non-invasive method for detecting and quantifying Myasthenia Gravis using electrooculography (EOG) signals.
• To establish standardized data collection protocols for acquiring EOG data in a clinical setting for MG assessment.
• To explore novel eye movement-based biomarkers for improved MG quantification.

Main Methods:

• Development of data collection protocols utilizing a standardized eye movement protocol.
• Acquisition of electrooculography (EOG) data in a standard clinical setting.
• Presentation of experimental setup, test protocols, sample outcomes, and preliminary analysis strategies.

Main Results:

• Demonstration of an experimental setup and protocols for acquiring EOG signals for MG quantification.
• Identification of common artifacts and discussion of technical/logistical challenges in EOG data acquisition.
• Preliminary analysis approaches for EOG data in the context of MG.

Conclusions:

• Electrooculography (EOG) offers a promising non-invasive approach for Myasthenia Gravis (MG) detection and quantification.
• Standardized protocols and eye movement-based biomarkers can facilitate widespread, early screening for MG.
• Further research and validation are needed to fully implement EOG as a clinical tool for MG diagnosis.